CN113476516A - External-use liquid medicine - Google Patents
External-use liquid medicine Download PDFInfo
- Publication number
- CN113476516A CN113476516A CN202110994337.9A CN202110994337A CN113476516A CN 113476516 A CN113476516 A CN 113476516A CN 202110994337 A CN202110994337 A CN 202110994337A CN 113476516 A CN113476516 A CN 113476516A
- Authority
- CN
- China
- Prior art keywords
- parts
- liquid medicine
- water
- raw materials
- external liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Obesity (AREA)
- Hematology (AREA)
Abstract
The invention provides an external liquid medicine, and relates to the technical field of traditional Chinese medicines. The external liquid medicine comprises the following raw materials in parts by mass: the external liquid medicine for treating new wounds comprises the following raw materials in parts by mass: 10-20 parts of green tangerine orange peel leaves, 2-6 parts of giant knotweed rhizome, 1-2 parts of lithospermum, 1-2 parts of astragalus membranaceus and 90-180 parts of water; the external liquid medicine for treating old wounds comprises the following raw materials in parts by mass: 15-25 parts of green tangerine orange peel leaves, 3-8 parts of giant knotweed, 1.5-2.5 parts of lithospermum, 1.5-2.5 parts of astragalus and 70-160 parts of water; the external liquid medicine for high-efficiency bacteriostasis and conventional wound infection comprises the following raw materials in parts by mass: 8-18 parts of green tangerine orange peel leaves, 0.8-1.3 parts of lithospermum, 0.8-1.3 parts of astragalus membranaceus, 2.5-5 parts of polygonum cuspidatum, 0.3-0.4 part of peppermint oil and 78-159 parts of water. Through the flexible combination of the medicines, the medicine has good treatment effect on new and old burns and scalds, viral wounds and canker sores, and is worthy of great popularization.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to an external liquid medicine.
Background
Burn and scald are common diseases which are sudden, are better developed in summer and autumn and exposed parts of a human body, and cause pain to patients in light cases and endanger life in serious cases. The medicines for treating the burns and scalds in the domestic market at present are various, but the effect is not satisfactory, the defects that the treatment effect is slow, the infection is easy, the treatment method is complicated, the cost is high, the burns and scalds of more than II degrees are clinically treated by adopting a bandaging treatment or an exposure treatment, the skin grafting is needed by manual operation, scars with different degrees are remained after the burns and scalds are healed, and the bedsore (pressure sore) is the pathological change of tissue necrosis caused by long-term compression of local tissues of an organism and blood circulation disturbance, ischemia and anoxia of skin and subcutaneous tissues, is common to the complications of long-term bedridden patients, and is a great problem in the international and domestic at present no matter treatment or nursing. In order to strengthen the prevention and control treatment of bedsore, a bedsore prevention and control organization system is respectively established in the United states and Europe, a series of related researches are carried out, positive effects on prevention and control are achieved, domestic bedsore treatment is reported, such as alginate silver ion application, moist burn ointment treatment and the like, but the effect is not ideal. If the bedsore is not treated in time, the bedsore is often infected at the same time, the illness condition is aggravated, and even the life of the patient is threatened.
The patent document CN101361842A discloses a Chinese herbal medicine burn and scald liquid, which is prepared from the following components, 70-100 parts of natural bark tree leaf juice, 20-30 parts of lithospermum, 5-10 parts of astragalus, 5-10 parts of dutchmanspipe root and 850 parts of water, the Chinese herbal medicine burn and scald liquid has quick curative effect and simple and convenient treatment method, only needs to be smeared on a wound surface at any time, has no pain and low cost, can not be infected in the treatment process, can heal the burn and scald without skin grafting no matter the burn and scald is light and serious, does not leave scars after healing, is convenient and simple to use, but has poor healing effect on a new burn and scald wound, and can not well activate blood and dredge the wound, promote diuresis and detoxify the wound.
The patent document CN106138143A discloses a pure traditional Chinese medicine liquid for treating burns, scalds and bedsores and a preparation method thereof, wherein the pure traditional Chinese medicine liquid is prepared from the following raw materials in parts by weight: 185-200 parts of Chinese ilex leaf, 15-20 parts of dutchmanspipe root and 800 parts of water. The preparation method comprises the following steps: picking folium Ilicis Purpureae, removing impurities, cleaning, adding water, pulverizing, and removing coarse residue to obtain suspension; grinding radix Aristolochice into powder, adding into the suspension, and stirring. The liquid medicine has particularly good effect on burns, scalds and bedsores, has good curative effect on burns and scalds, but has not ideal curative effect on old wounds, and can not well inhibit bacteria and has poor curative effect when the old wounds are treated.
The published patent document CN109999083A discloses an external liquid medicine for burns, scalds and bedsores, which comprises the following components in parts by weight: the raw materials are taken in parts by weight as follows: 70-100 parts of Chinese ilex leaf, 20-30 parts of giant knotweed, 5-10 parts of lithospermum, 5-10 parts of astragalus and 850-inch water. The invention adopts natural therapy, has quick curative effect, shortens the healing time by 1 to 2 times compared with the prior medicaments and treatment methods in the market, has simple and convenient treatment method, only needs the liquid medicine to be deeply rubbed or sprayed on the surface of the wound once every 1 to 2 hours as long as the wound is not infected and purulent, does not need complicated debridement, disinfection, bandaging, dressing change and strict aseptic environment and nursing, has no scars after healing no matter light and heavy burns and scalds, does not have secondary infection in the treatment process, can heal the wound without artificial operation skin grafting, does not leave scars after healing, has low cost, has the treatment cost which is about 10 to 15 percent of that of other medicaments and treatment methods, has wide medicament sources and simple and convenient preparation, can well disinfect and promote the healing of the burn and scald surfaces of the wound, but has poor bacteriostatic effect when the liquid medicine is clinically used, can not well protect the surface of the wound and has narrow pertinence, cannot be used for treating conventional viral infection and oral ulcer.
Disclosure of Invention
Technical problem to be solved
Aiming at the defects of the prior art, the invention provides the external liquid medicine, and solves the problems of narrow use range and poor healing effect of the medicine.
(II) technical scheme
In order to achieve the purpose, the invention is realized by the following technical scheme: the external liquid medicine comprises the following raw materials in parts by mass:
the external liquid medicine for treating new wounds comprises the following raw materials in parts by mass: 10-20 parts of green tangerine orange peel leaves, 2-6 parts of giant knotweed rhizome, 1-2 parts of lithospermum, 1-2 parts of astragalus membranaceus and 90-180 parts of water.
Preferably, the external liquid medicine comprises the following raw materials in parts by weight:
the external liquid medicine for treating old wounds comprises the following raw materials in parts by mass: 15-25 parts of green tangerine orange peel leaves, 3-8 parts of giant knotweed rhizome, 1.5-2.5 parts of lithospermum, 1.5-2.5 parts of astragalus and 70-160 parts of water.
Preferably, the external liquid medicine comprises the following raw materials in parts by weight:
the external liquid medicine for high-efficiency bacteriostasis and conventional wound infection comprises the following raw materials in parts by mass: 8-18 parts of green tangerine orange peel leaves, 0.8-1.3 parts of lithospermum, 0.8-1.3 parts of astragalus membranaceus, 2.5-5 parts of polygonum cuspidatum, 0.3-0.4 part of peppermint oil and 78-159 parts of water.
Preferably, the preparation method of the external liquid medicine comprises the following steps:
the method comprises the following steps:
selecting clean green tangerine orange peel leaves, cleaning, mixing the green tangerine orange peel leaves with water, then crushing the green tangerine orange peel leaves, using a nano crusher when crushing, and then filtering large-particle impurities of the green tangerine orange peel leaves by using a 20-50 mesh screen to obtain green tangerine orange peel leaf filtrate for later use;
step two:
removing dust and impurities from lithospermum and polygonum cuspidatum, crushing the lithospermum and the polygonum cuspidatum by using an airflow crusher at the temperature of 5-18 ℃, then screening the lithospermum and the polygonum cuspidatum by using a 50-80-mesh screen, repeatedly grinding the lithospermum and the polygonum cuspidatum until all the lithospermum and the polygonum cuspidatum pass through the screen to obtain mixed powder, mixing the mixed powder and water in a ratio of 1:10, putting the mixed powder and the water into a reaction kettle, keeping the temperature of 30-75 ℃ for 1-2 hours, simultaneously performing ultrasonic vibration treatment, and then taking out the mixed powder to obtain a mixed raw material;
step three:
decocting radix astragali and water in a casserole at a volume ratio of 1:20, decocting with slow fire for 40 minutes after the water is boiled, continuously adding clear water during the decocting process to ensure that half of the water is left after the decocting is finished, and filtering with gauze to obtain radix astragali water.
Preferably, the preparation method of the external liquid medicine for treating new wounds comprises the following steps: mixing the astragalus mongholicus water in the third step, the ilex chinensis leaf filtrate in the first step and the mixed raw materials in the second step to obtain a liquid medicine for treating new wounds.
Preferably, the folium Ilicis Purpureae filtrate in the step one, the mixed raw materials in the step two and the radix astragali water in the step three are mixed to obtain the external liquid medicine for treating old wounds.
Preferably, the astragalus membranaceus water, the peppermint oil, the folium ilicis chinensis filtrate in the first step and the mixed raw materials in the second step are uniformly and fully mixed to obtain the external liquid medicine for efficiently inhibiting bacteria and normally infecting wounds.
(III) advantageous effects
The invention provides a liquid medicine for external use. The method has the following beneficial effects:
1. the invention uses the combination of the green tangerine orange peel leaves, the giant knotweed rhizome, the sinkiang arnebia root and the astragalus root for treating the new wound, and the combination of a plurality of medicines to ensure that the liquid medicine has the functions of clearing away heat and toxic material, promoting blood circulation and stimulating the menstrual flow, inducing diuresis and removing toxicity after being coated on the affected part, so that the new wound can inhibit the propagation of bacteria and can quickly heal the new wound, relieve swelling and pain, promote the self-repair of soft tissues during the treatment, ensure that the wound caused by burn and scald can be quickly recovered, and can reduce the infection chance, because of the inherent characteristics of the closed dressing, the closed dressing has the barrier function on the microorganisms in the external environment, the clinical application shows that the wound infection probability is only 2.6 percent, compared with the traditional treatment method, the infection chance is greatly reduced, the pain and the repeated injury can be reduced, the moist environment avoids the excessive evaporation of the exudate of the wound to form dry crust, and the repeated injury of changing the medicine to promote the wound healing, meanwhile, the nerve endings of the wound surface can not be directly exposed in the air to feel pain due to the moisture.
2. The invention makes the external liquid medicine have strong effects of bacteriostasis, sterilization, removing putrefaction and promoting granulation by matching the green tangerine orange peel leaves, the giant knotweed rhizome, the sinkiang arnebia root and the astragalus root for treating old wounds, so that the external liquid medicine has the function of protecting the wound surface, the tannin component contained in the medicine can be rapidly combined with fibrin exuded from tissues to form a scab membrane, form a protective barrier for broken capillaries, effectively prevent the invasion of bacteria, control the infection and the loss of body fluid, and is beneficial to preventing the occurrence of shock and septicemia, can be debrided by oneself, in a moist environment, necrotic tissues can be hydrated by exudates to release fibrinolytic enzymes and other proteolytic enzymes of tissue cells, the lyases are beneficial to absorption to achieve the debridement effect, and in addition, the protein degradation product FDP is also a chemotactic factor of immune cells, can attract the immune cells to move to the wound surface, and accelerates the debridement process.
3. The invention synthesizes external liquid medicine by green tangerine orange peel leaves, lithospermum, astragalus, giant knotweed and peppermint oil which are used for high-efficiency bacteriostasis and conventional infected wounds, the liquid medicine can inhibit and kill bacteria, experiments prove that protocatechuic acid contained in the medicine has broad-spectrum bacteriostasis and sterilization effects, and has different degrees of inhibition and killing effects on pseudomonas aeruginosa, escherichia coli, typhoid bacillus, dysentery bacillus, alcaligenes, bacillus subtilis, staphylococcus aureus and the like, and in the clinical application process, the medicine is used for treating various intractable surgical infectious diseases according to the pharmacological action and mechanism, such as: diabetic foot, cellulitis, canker sores, eczema with infection, incision infections and various traumas such as: satisfactory effects are obtained for the treatment of bruise, contusion, etc.
4. The liquid medicine can accelerate healing and shorten treatment time, the microcirculation environment of the part of the wound surface under the moist closed dressing often forms low-oxygen tension, and fibroblasts grow at the fastest speed in a relatively low-oxygen environment, and stimulate multiple growth factors of macrophages, so that the formation of blood vessels is accelerated, the formation of granulation tissues is promoted, and the healing time of the wound surface is shortened. Meanwhile, the activity of cells and enzyme can be kept under a humid environment, water is needed to be used as a medium for cell proliferation and differentiation and enzyme activity exertion, the humid environment can retain active substances in exudate and promote the release of the active substances, a wound exudate contains various growth factors such as PDGF, beta-TGF and the like, the growth factors play an important regulation role in the wound healing process, and the growth factors can stimulate the proliferation of fibroblasts and are chemical catalysts of macrophages, neutrophils and smooth muscle cells, so that the wound healing is accelerated, and the wound healing is worthy of vigorous popularization.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The first embodiment is as follows:
the embodiment of the invention provides an external liquid medicine which comprises the following raw materials in parts by weight:
the external liquid medicine for treating new wounds comprises the following raw materials in parts by mass: 20 parts of green tangerine orange peel leaves, 6 parts of giant knotweed rhizome, 2 parts of sinkiang arnebia root, 2 parts of astragalus root and 180 parts of water, and the combination of a plurality of medicines, after the liquid medicine is coated on an affected part, the new wound can not only inhibit the propagation of bacteria but also can be quickly healed in the treatment process, the swelling and pain can be reduced, the self-repair of soft tissues can be promoted, the wound of burn and scald can be quickly recovered, the infection chance can be reduced, and due to the inherent characteristics of the closed dressing, it has the function of obstructing the microorganisms in the external environment, so the clinical application shows that the wound infection probability is only 2.6 percent, the infection probability is greatly reduced compared with the traditional treatment method, the preparation can reduce pain and repeated injury, avoid the excessive evaporation of wound exudate to form dry scab in a humid environment, prevent repeated injury due to dressing change to promote wound healing, and prevent nerve endings of the wound from being directly exposed in the air to feel pain due to humidification.
The external liquid medicine for treating old wounds comprises the following raw materials in parts by mass: 25 parts of green tangerine orange peel leaves, 8 parts of giant knotweed rhizome, 2.5 parts of sinkiang arnebia root, 2.5 parts of astragalus root and 160 parts of water, wherein tannin components contained in the medicine can be rapidly combined with fibrin exuded from tissues to form a scab membrane, a protective barrier is formed for damaged capillaries, the invasion of bacteria is effectively prevented, the infection and the loss of body fluid are controlled, the occurrence of shock and septicemia can be prevented, the wound can be debrided by self, necrotic tissues can be hydrated by exudates under a humid environment to release fibrinolytic enzymes and other proteolytic enzymes of histiocytes, the lytic enzymes are easy to absorb to achieve a debridement effect, and in addition, protein degradation products FDP are chemotactic factors of immunocytes, and can attract immunocytes to move to a wound surface and accelerate a debridement process.
The external liquid medicine for high-efficiency bacteriostasis and conventional infection of wounds comprises the following raw materials in parts by mass: the medicine comprises 18 parts of green tangerine orange peel leaves, 1.3 parts of lithospermum, 1.3 parts of astragalus, 5 parts of polygonum cuspidatum, 0.4 part of peppermint oil and 159 parts of water, and experiments prove that protocatechuic acid contained in the medicine has broad-spectrum antibacterial and bactericidal effects, and has different degrees of inhibiting and killing effects on pseudomonas aeruginosa, escherichia coli, typhoid bacillus, dysentery bacillus, alcaligenes, bacillus subtilis, staphylococcus aureus and the like, and in the clinical application process, the medicine is used for treating various intractable surgical infectious diseases according to the pharmacological action and mechanism, such as: diabetic foot, cellulitis, canker sores, eczema with infection, incision infections and various traumas such as: satisfactory effects are obtained for the treatment of bruise, contusion, etc.
The preparation method of the external liquid medicine comprises the following preparation steps:
the method comprises the following steps:
selecting clean green tangerine orange peel leaves, cleaning, mixing the green tangerine orange peel leaves with water, then crushing the green tangerine orange peel leaves, using a nano crusher when crushing, and then filtering large-particle impurities of the green tangerine orange peel leaves by using a 50-mesh screen to obtain green tangerine orange peel leaf filtrate for later use;
step two:
removing dust and impurities from lithospermum and polygonum cuspidatum, crushing the lithospermum and the polygonum cuspidatum by using an airflow crusher at the temperature of 18 ℃, then screening the lithospermum and the polygonum cuspidatum by using a 80-mesh screen, repeatedly grinding the lithospermum and the polygonum cuspidatum until all the lithospermum and the polygonum cuspidatum pass through the screen to obtain mixed powder, mixing the mixed powder and water in a ratio of 1:10, putting the mixed powder into a reaction kettle, keeping the temperature at 75 ℃ for 2 hours, simultaneously using ultrasonic vibration for treatment, and then taking out the mixed powder to obtain a mixed raw material;
step three:
decocting radix astragali and water in a casserole at a volume ratio of 1:20, decocting with slow fire for 40 minutes after the water is boiled, continuously adding clear water during the decocting process to ensure that half of the water is left after the decocting is finished, and filtering with gauze to obtain radix astragali water.
The preparation method of the external liquid medicine for treating new wounds comprises the following steps: mixing the astragalus mongholicus water in the third step, the ilex chinensis leaf filtrate in the first step and the mixed raw materials in the second step to obtain a liquid medicine for treating new wounds.
The preparation method of the external liquid medicine for treating old wounds comprises the following steps: the preparation method of the external liquid medicine for treating old wounds comprises the following steps: and (3) mixing the ilex chinensis leaf filtrate in the step one, the mixed raw materials in the step two and the astragalus membranaceus water in the step three to obtain the external liquid medicine for treating old wounds.
The preparation method of the external liquid medicine for high-efficiency bacteriostasis and conventional infection of wounds comprises the following steps: uniformly and fully mixing the astragalus mongholicus water, the peppermint oil, the ilex chinensis leaf filtrate in the step one and the mixed raw materials in the step two in the step three to obtain an external liquid medicine for efficiently inhibiting bacteria and normally infecting wounds;
in conclusion, through clinical use and research, no matter a few degrees of burns or bedsores exist, secondary infection cannot occur in the treatment process, and the external treatment of local small-area III-degree burns and scalds and patients with bedsores below III can enable the wound to heal naturally and no scar is left after healing;
the treatment method is simple and convenient without pain, the product treats the burns and scalds and the bedsore below the III stage, does not need complicated debridement, disinfection, bandaging, dressing change and special sterile environment and nursing, and only needs to paint the liquid medicine on the wound surface for 1 time every 1 to 2 hours until the wound naturally heals, exfoliates and heals;
the treatment cost is low, and the total cost is less than 10 to 15 percent of other treatment methods;
the use is convenient, and in clinical application for more than 40 years, over 80 percent of small-area burns and scalds and decubitus ulcers below the III stage are treated by the product at home;
the medicine used in the liquid medicine has the effects of clearing heat and detoxicating, relieving swelling and pain, inhibiting bacteria and killing bacteria, removing putrefaction and promoting tissue regeneration, large-area burn and scald cases and bedsores with other diseases are treated internally according to the conventional western medicine, the external product is smeared on the wound surface (6-8 times per day) until the wound is naturally healed, and local shallow burns and scalds below II degrees and bedsore cases below III stage can be automatically cured by singly using the product, if mistreatment is met, patients infected with pyogenesis and patients with bedsores above III stage are treated by thoroughly removing pus and sterilizing, and then the product is used for treating. Other infectious surgical wounds were treated in the same manner as sores.
Example two:
the embodiment of the invention provides an external liquid medicine which comprises the following raw materials in parts by weight:
the external liquid medicine for treating new wounds comprises the following raw materials in parts by mass: 10 parts of green tangerine orange peel leaves, 2 parts of giant knotweed rhizome, 1 part of lithospermum, 1 part of astragalus and 90 parts of water.
The external liquid medicine for treating old wounds comprises the following raw materials in parts by mass: 15 parts of green tangerine orange peel leaves, 3 parts of giant knotweed rhizome, 1.5 parts of lithospermum, 1.5 parts of astragalus and 70 parts of water.
The external liquid medicine for high-efficiency bacteriostasis and conventional wound infection comprises the following raw materials in parts by mass: 8 parts of green tangerine orange peel leaves, 0.8 part of lithospermum, 0.8 part of astragalus, 2.5 parts of giant knotweed, 0.3 part of peppermint oil and 78 parts of water;
the liquid medicine can accelerate healing and shorten the treatment time, the microcirculation environment of the part of the wound surface under the moist closed dressing often forms low-oxygen tension, the fibroblast grows at the fastest speed in a relatively low-oxygen environment, and multiple growth factors of macrophages are stimulated, so that the formation of blood vessels is accelerated, the formation of granulation tissues is promoted, and the healing time of the wound surface is shortened. Meanwhile, the activity of cells and enzyme can be kept under a humid environment, water is needed to be used as a medium for cell proliferation and differentiation and enzyme activity exertion, the humid environment can retain active substances in exudate and promote the release of the active substances, a wound exudate contains various growth factors such as PDGF, beta-TGF and the like, the growth factors play an important regulation role in the wound healing process, and the growth factors can stimulate the proliferation of fibroblasts and are also chemical catalysts of macrophages, neutrophils and smooth muscle cells, so that the wound healing is accelerated.
The preparation method of the external liquid medicine comprises the following preparation steps:
the method comprises the following steps:
selecting clean green tangerine orange peel leaves, cleaning, mixing the green tangerine orange peel leaves with water, then crushing the green tangerine orange peel leaves, using a nano crusher when crushing, and then filtering large-particle impurities of the green tangerine orange peel leaves by using a 20-mesh screen to obtain green tangerine orange peel leaf filtrate for later use;
step two:
removing dust and impurities from lithospermum and polygonum cuspidatum, crushing the lithospermum and the polygonum cuspidatum by using an airflow crusher at the temperature of 5 ℃, then screening the lithospermum and the polygonum cuspidatum by using a 50-mesh screen, repeatedly grinding the lithospermum and the polygonum cuspidatum until all the lithospermum and polygonum cuspidatum pass through the screen to obtain mixed powder, mixing the mixed powder and water in a ratio of 1:10, putting the mixed powder into a reaction kettle, keeping the temperature at 30 ℃ for 1 hour, simultaneously using ultrasonic vibration treatment, and then taking out the mixed powder to obtain a mixed raw material;
step three:
decocting radix astragali and water in a casserole at a volume ratio of 1:20, decocting with slow fire for 40 minutes after the water is boiled, continuously adding clear water during the decocting process to ensure that half of the water is left after the decocting is finished, and filtering with gauze to obtain radix astragali water.
The preparation method of the external liquid medicine for treating new wounds comprises the following steps: mixing the astragalus mongholicus water in the third step, the ilex chinensis leaf filtrate in the first step and the mixed raw materials in the second step to obtain a liquid medicine for treating new wounds.
The preparation method of the external liquid medicine for treating old wounds comprises the following steps: and (3) mixing the ilex chinensis leaf filtrate in the step one, the mixed raw materials in the step two and the astragalus membranaceus water in the step three to obtain the external liquid medicine for treating old wounds.
The preparation method of the external liquid medicine for high-efficiency bacteriostasis and conventional infection wound comprises the following steps: uniformly and fully mixing the astragalus mongholicus water, the peppermint oil, the ilex chinensis leaf filtrate in the step one and the mixed raw materials in the step two in the step three to obtain an external liquid medicine for efficiently inhibiting bacteria and normally infecting wounds;
in summary, when the patient uses the medical solution, the first case: a patient can be treated by the product at home and can be basically healed because of atrophic neuritis, paralysis can be kept for 11 years, and the area of the bedsore is 22 multiplied by 16cm when the patient is complicated by buttocks and cannot be staged.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (7)
1. The external liquid medicine is characterized in that: the composite material comprises the following raw materials in parts by mass:
the external liquid medicine for treating new wounds comprises the following raw materials in parts by mass: 10-20 parts of green tangerine orange peel leaves, 2-6 parts of giant knotweed rhizome, 1-2 parts of lithospermum, 1-2 parts of astragalus membranaceus and 90-180 parts of water.
2. The external liquid medicine is characterized in that: the composite material comprises the following raw materials in parts by mass:
the external liquid medicine for treating old wounds comprises the following raw materials in parts by mass: 15-25 parts of green tangerine orange peel leaves, 3-8 parts of giant knotweed rhizome, 1.5-2.5 parts of lithospermum, 1.5-2.5 parts of astragalus and 70-160 parts of water.
3. The external liquid medicine is characterized in that: the composite material comprises the following raw materials in parts by mass:
the external liquid medicine for high-efficiency bacteriostasis and conventional wound infection comprises the following raw materials in parts by mass: 8-18 parts of green tangerine orange peel leaves, 0.8-1.3 parts of lithospermum, 0.8-1.3 parts of astragalus membranaceus, 2.5-5 parts of polygonum cuspidatum, 0.3-0.4 part of peppermint oil and 78-159 parts of water.
4. The method for preparing a liquid medicine for external use according to claim 1, 2 or 3, characterized in that: the preparation steps are as follows:
the method comprises the following steps:
selecting clean green tangerine orange peel leaves, cleaning, mixing the green tangerine orange peel leaves with water, then crushing the green tangerine orange peel leaves, using a nano crusher when crushing, and then filtering large-particle impurities of the green tangerine orange peel leaves by using a 20-50 mesh screen to obtain green tangerine orange peel leaf filtrate for later use;
step two:
removing dust and impurities from lithospermum and polygonum cuspidatum, crushing the lithospermum and the polygonum cuspidatum by using an airflow crusher at the temperature of 5-18 ℃, then screening the lithospermum and the polygonum cuspidatum by using a 50-80-mesh screen, repeatedly grinding the lithospermum and the polygonum cuspidatum until all the lithospermum and the polygonum cuspidatum pass through the screen to obtain mixed powder, mixing the mixed powder and water in a ratio of 1:10, putting the mixed powder and the water into a reaction kettle, keeping the temperature of 30-75 ℃ for 1-2 hours, simultaneously performing ultrasonic vibration treatment, and then taking out the mixed powder to obtain a mixed raw material;
step three:
decocting radix astragali and water in a casserole at a volume ratio of 1:20, decocting with slow fire for 40 minutes after the water is boiled, continuously adding clear water during the decocting process to ensure that half of the water is left after the decocting is finished, and filtering with gauze to obtain radix astragali water.
5. The method for preparing a liquid medicine for external use according to claims 1 and 4, characterized in that: the preparation method of the external liquid medicine for treating new wounds comprises the following steps: mixing the astragalus mongholicus water in the third step, the ilex chinensis leaf filtrate in the first step and the mixed raw materials in the second step to obtain a liquid medicine for treating new wounds.
6. The method for preparing a liquid medicine for external use according to claims 2 and 4, characterized in that: the preparation method of the external liquid medicine for treating old wounds comprises the following steps: and (3) mixing the ilex chinensis leaf filtrate in the step one, the mixed raw materials in the step two and the astragalus membranaceus water in the step three to obtain the external liquid medicine for treating old wounds.
7. The method for preparing a liquid medicine for external use according to claims 3 and 4, characterized in that: the preparation method of the external liquid medicine for high-efficiency bacteriostasis and conventional infection wound comprises the following steps: and (3) uniformly and fully mixing the astragalus mongholicus water, the peppermint oil, the ilex chinensis leaf filtrate in the step one and the mixed raw materials in the step two in the step three to obtain the external liquid medicine for efficiently inhibiting bacteria and normally infecting wounds.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110994337.9A CN113476516A (en) | 2021-08-27 | 2021-08-27 | External-use liquid medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110994337.9A CN113476516A (en) | 2021-08-27 | 2021-08-27 | External-use liquid medicine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113476516A true CN113476516A (en) | 2021-10-08 |
Family
ID=77946308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110994337.9A Pending CN113476516A (en) | 2021-08-27 | 2021-08-27 | External-use liquid medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113476516A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361842A (en) * | 2008-09-24 | 2009-02-11 | 李朝阳 | Chinese herbal medicine liquid medicine for treating burn and scald |
| CN109999083A (en) * | 2019-04-02 | 2019-07-12 | 李朝阳 | A kind of burn and scald, external application bedsore drug liquid |
-
2021
- 2021-08-27 CN CN202110994337.9A patent/CN113476516A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101361842A (en) * | 2008-09-24 | 2009-02-11 | 李朝阳 | Chinese herbal medicine liquid medicine for treating burn and scald |
| CN109999083A (en) * | 2019-04-02 | 2019-07-12 | 李朝阳 | A kind of burn and scald, external application bedsore drug liquid |
Non-Patent Citations (1)
| Title |
|---|
| 杨俊等: "自制复方紫草油治疗压疮疗效观察", 《四川中医》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Molan et al. | Clinical usage of honey as a wound dressing: an update | |
| US8425942B2 (en) | Method for sterilizing unheated raw honey, a honey-based wound care preparation, a wound care treatment product, and a biscuit based on honey | |
| CN1044973C (en) | Burn ointment | |
| CN106728727A (en) | It is a kind of to treat ointment of sore and preparation method thereof | |
| CN101569696A (en) | Chinese medicament for traumatic wound | |
| CN106581439A (en) | Traditional Chinese medicine composition for treating wounds, diabetic feet and skin ulceration, and preparation method thereof | |
| CN102357203B (en) | Cortex ulmis burn ointment for curing burns | |
| CN101455748B (en) | Inflammation-diminishing tissue-regeneration medicine and preparation method thereof | |
| CN101822783A (en) | Western and Chinese medicine powder for externally treating pressure ulcer | |
| CN101837094B (en) | External Chinese medicinal preparation for curing bedsore | |
| CN113476516A (en) | External-use liquid medicine | |
| CN1176709C (en) | Drug for curing scald, hrut and inflammations as well as hemorrhoids | |
| CN109731040A (en) | A kind of wound remediation composition, preparation method and applications | |
| CN113559311B (en) | Medical antibacterial hemostatic gel dressing and preparation method thereof | |
| CN1058627C (en) | Compound arnebia root paste for curing heat injury of human body and its preparing method | |
| Hammouri | The role of honey in the management of diabetic foot ulcers | |
| CN1204909C (en) | Ointment made of Chinese medicinal herbs for treating bedsore difficult to cure | |
| CN1072499C (en) | External-use medicine for curing various chronic ulcers | |
| CN110801464A (en) | Sanhua energy-gathering wound emergency medicine oil and preparation method thereof | |
| CN101036712A (en) | Scald and burn ointment | |
| CN101647952A (en) | Flesh engendering and wound closing medicament for external use | |
| CN106138143A (en) | Pure Chinese medicine burn and scald, bedsore treatment liquid and preparation method thereof | |
| Shete et al. | A Comprehensive Review on Wound Dressings and Their Comparative Effectiveness on Healing of Contaminated Wounds and Ulcers | |
| CN108310220B (en) | Pharmaceutical composition for treating bedsore and preparation method and application thereof | |
| CN114886967B (en) | Externally-applied traditional Chinese medicine composition for promoting tissue regeneration and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211008 |